Each year, on the third Thursday of November, smokers across the nation take part in the American Cancer Society Great American Smokeout event. Encourage someone you know to use this day to create a plan to quit! Quitting smoking is an important step toward a healthier life and reducing cancer risk.
According to the American Cancer Society, approximately “36.5 million Americans still smoke cigarettes, and tobacco remains the single largest preventable cause of disease and premature death in the world. Quitting smoking has immediate and long-term benefits at any age. Quitting is hard, but you can increase your chances of success with help. Getting help through counseling or medications can double or triple the chances of quitting successfully.”
Tria Health provides personalized chronic condition management (CCM) to help employers and health plans mitigate risks and control health care costs. In addition to our Pharmacy Advocate program, Specialty GuardRx and Rx Plan Protection Suite, Tobacco users impose significant excess cost to private employers.
Tria Health’s S.T.O.P. program has an overall 42% success rate of getting members to 90 days tobacco free! Tria pharmacists develop a personalized quit plan which helps to improve success because every smoker has unique needs. They base the plan on many factors including: level of motivation, barriers to quitting, treatment options, and more. They provide on-going support to members to ensure success.
If you or someone you know are still smoking cigarettes, all of us at Tria Health encourage you to use The Great American Smokeout on November 16th to create a plan to quit!
According to the American Diabetes Association, diabetes affects 30 million Americans, including 8.1 million people who are undiagnosed. Another 86 million more—one in three adults—have prediabetes and 15-30 percent will develop diabetes within five years without change.
The Scary Statistics
People with type 2 diabetes have more than two times the risk for developing heart disease
People with diabetes live 7-8 years less
Two out of three deaths in people with type 2 diabetes are attributed to cardiovascular disease
Less than half of people with diabetes are aware of their risk of cardiovascular disease. This lack of awareness prevents people with diabetes and their health care providers from addressing risks and improving health.
The Partnership to Fight Chronic Disease states that “the increased co-occurrence of diabetes and cardiovascular disease demands greater awareness to save lives and health care dollars.”
At Tria Health, that’s precisely what we do—we manage the whole patient, and discuss all their conditions, prescription medications, over-the-counter medications and their lifestyle. Our pharmacists educate their patients about their medications and make recommendations to the patients and their prescribing physicians to improve clinical outcomes.
A Tria Health Patient Success Story
During an initial pharmacist consultation, it was documented that the patient’s HgbA1c was too high – indicating poorly controlled Diabetes. In addition, the patient had significant financial difficulties affording certain medications increasing medication non-adherence. The patient was initially prescribed Metformin, but stopped taking the medication due to stomach problems without replacing it with any other diabetes medication. The pharmacist recommended a prescription of Glimepiride since it is inexpensive, very effective, and generally well tolerated. The patient’s physician agreed with the recommendation and the patient has achieved a HgbA1c of 8% in one year
In addition, the Tria pharmacist recommended switching from brand-named Benicar-HCT, a blood pressure medication, to a similarly available generic blood pressure medication called Losartan-HCTZ. The generic version saved the member $40 every 30 days and the patient’s blood pressure remains well controlled on Losartan-HCTZ.
The patient initially had success and then set-backs with smoking cessation. The Tria pharmacist worked with them to achieve sustained smoking cessation and improved health by identifying appropriate therapies and by providing ongoing education and coaching.
This success story illustrates that by managing the whole patient, and all their conditions, can and will improve clinical and financial outcomes.